Literature DB >> 28633700

Trends in drug-resistant tuberculosis after the implementation of the DOTS strategy in Shenzhen, China, 2000-2013.

L Zhu1, Y-Z Yang2, H-Y Guan2, S-M Cheng3, Y-Y Jin4, W-G Tan2, Q-F Wu2, X-L Liu2, M-G Zhao2, Z-H Lu5, Z-W Jia6.   

Abstract

SETTING: The DOTS strategy has been regarded as the most cost-effective way to stop the spread of tuberculosis (TB) since its launch by the World Health Organization.
OBJECTIVE: To estimate the effects of DOTS by tracking long-term trends in multidrug-resistant TB (MDR-TB).
DESIGN: A retrospective cohort study was conducted from 2000 to 2013 to analyse trends in resistance to anti-tuberculosis drugs and the effect of DOTS-based treatment in Shenzhen, China, using the χ2 test.
RESULTS: An overall MDR-TB rate of 4.2% was observed between 2000 and 2013, with an annual reduction of 0.16%. From 2000 to 2013, trends in resistance to isoniazid (INH), rifampicin (RMP) and MDR-TB declined significantly in new TB patients (P < 0.01), but not in retreatment cases. Sputum smear conversion rates after 2 months of treatment decreased significantly, in particular after 2007, in new and retreatment cases.
CONCLUSION: INH and RMP resistance and MDR-TB rates declined significantly, suggesting that DOTS-based programmes were successful in reducing drug resistance in new cases but not in retreatment cases. The decreasing sputum smear conversion rates may have been due to an increase in the number of migrants. These two findings suggest that TB is unlikely to be completely eliminated by 2050 in Shenzhen.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28633700     DOI: 10.5588/ijtld.16.0759

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  4 in total

1.  A 10-Year Comparative Analysis Shows that Increasing Prevalence of Rifampin-Resistant Mycobacterium tuberculosis in China Is Associated with the Transmission of Strains Harboring Compensatory Mutations.

Authors:  Fengmin Huo; Jingjing Luo; Jin Shi; Zhaojing Zong; Wei Jing; Wenzhu Dong; Lingling Dong; Yifeng Ma; Qian Liang; Yuanyuan Shang; Hairong Huang; Yu Pang
Journal:  Antimicrob Agents Chemother       Date:  2018-03-27       Impact factor: 5.191

2.  Predictors and Trends of MDR/RR-TB in Shenzhen China: A Retrospective 2012-2020 Period Analysis.

Authors:  Ji Lecai; Peierdun Mijiti; Hong Chuangyue; Li Mingzhen; Gao Qian; Tan Weiguo; Chen Jihong
Journal:  Infect Drug Resist       Date:  2021-10-27       Impact factor: 4.003

3.  Glyoxal damages human aortic endothelial cells by perturbing the glutathione, mitochondrial membrane potential, and mitogen-activated protein kinase pathways.

Authors:  Ming-Zhang Xie; Lu-Yang Jiao; Guo-An Zhao; Chun Guo; Jia-Qi Dong; Jie Zhang; Ke-Tao Sun; Guang-Jian Lu; Lei Wang; De-Ying Bo
Journal:  BMC Cardiovasc Disord       Date:  2021-12-18       Impact factor: 2.298

4.  Bridging the Gap in End Tuberculosis Targets in the Elderly Population in Eastern China: Observational Study From 2015 to 2020.

Authors:  Kui Liu; Zhenhua Xie; Gaofeng Cai; Bin Chen; Bo Xie; Songhua Chen; Yu Zhang; Wei Wang; Qian Wu
Journal:  JMIR Public Health Surveill       Date:  2022-07-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.